Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
absolute bioavailability | systemic availability relative to an intravenous reference with dose adjustment | The study estimated absolute bioavailability using paired oral and intravenous data. | Assessment | Drug concentrations, exposure and assay interpretation |
absorption interaction | coadministration changes how much or how quickly a dose is absorbed | The absorption interaction was considered after reviewing timing with minerals and meals. | Assessment | Medication response, exposure and reconciliation |
administration record review | checking the record of doses actually given | Use the administration record review to verify the two doses preceding the sample. | Plan | Medication reconciliation, administration and teaching |
administration time | when the patient actually received a dose | The recorded administration time was later than the scheduled time. | Objective | Drug levels - collection and dose timing |
adverse effect diary | record of symptoms timed to doses and other relevant events | Use an adverse effect diary to document the pattern before the next review. | Plan | Medication reconciliation, administration and teaching |
as-needed indication | specific symptom or situation for which an as-needed dose may be taken | Add the as-needed indication in the patient's preferred wording to the schedule. | Plan | Medication reconciliation, administration and teaching |
attempted demand | button press requesting a patient-controlled dose | Attempted demand was counted separately from delivered doses in the pump record. | Objective | Vascular access and infusion observations |
AUC extrapolated to infinity | total single-dose exposure estimated beyond the last sample using terminal decline | The AUC extrapolated to infinity includes a separately reported extrapolated portion. | Assessment | Drug concentrations, exposure and assay interpretation |
bioavailability | fraction of a dose reaching the systemic circulation unchanged | A formulation change may have altered bioavailability. | Assessment | Medication response and safety |
blister pack | sealed compartment packaging for individual doses | Ask pharmacy whether a blister pack is available for this regimen. | Plan | Therapies, devices and interdisciplinary care |
| dose delivered over a short interval | Document the bolus separately from the subsequent infusion. | Plan | Drug levels - verification and documentation | |
bolus administration time | actual time a discrete dose was delivered | Bolus administration time was confirmed from the medication administration record. | Objective | Vascular access and infusion observations |
corrected count increment | platelet response to transfusion adjusted for body size and platelet dose | Corrected count increment was calculated using the timed posttransfusion count. | Objective | Hematology and transfusion laboratory reporting |
digoxin | cardiac glycoside for which dose-to-draw time affects concentration interpretation | The digoxin result was collected two hours after the reported dose. | Objective | Drug levels - named analytes and exposure reports |
dosing interval | time between successive doses | The last observed dosing interval was longer than the prescribed interval. | Objective | Drug levels - collection and dose timing |
extended infusion | individual dose infused over a prolonged defined time | Confirm the duration of the extended infusion from the pump history. | Plan | Drug levels - verification and documentation |
factor replacement recovery | measured increase in factor activity following an administered factor dose | Factor replacement recovery was assessed using paired baseline and timed samples. | Objective | Coagulation, antibodies and hemostasis studies |
first-pass extraction | presystemic removal before an absorbed dose reaches systemic circulation | The route change prompted review of possible first-pass extraction. | Assessment | Drug concentrations, exposure and assay interpretation |
inject | deliver a dose through a needle or injection device | Observe the caregiver practicing how to inject using a training pen. | Plan | Medication planning, access and administration |
| time between doses or observations | Verify the dosing interval on the discharge prescription. | Plan | Medication use and pharmacy documentation | |
linear kinetics | concentration or exposure changes proportionally with dose under stated conditions | The dosing model assumes linear kinetics over the range examined. | Assessment | Drug levels - exposure and pharmacokinetics |
line dead space | internal volume through which a dose or sample must pass | The line dead space was considered when reconciling the time a small infusion reached the patient. | Objective | Vascular access and infusion observations |
lockout interval | programmed minimum interval between permitted patient-triggered doses | The lockout interval was checked against the active pump order. | Objective | Vascular access and infusion observations |
medication calendar | dated schedule showing planned doses and changes | Provide a medication calendar for the transition between formulations. | Plan | Therapies, devices and interdisciplinary care |
methotrexate | antimetabolite with protocol-timed levels in high-dose treatment | The methotrexate result is identified by hours from the protocol-defined infusion start. | Objective | Drug levels - named analytes and exposure reports |